• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌发生过程中的呼吸道肿瘤微生物组:我们目前的进展如何?

Respiratory Tract Oncobiome in Lung Carcinogenesis: Where Are We Now?

作者信息

Czarnecka-Chrebelska Karolina H, Kordiak Jacek, Brzeziańska-Lasota Ewa, Pastuszak-Lewandoska Dorota

机构信息

Department of Biomedicine and Genetics, Medical University of Lodz, Mazowiecka 5, 92-215 Lodz, Poland.

Department of Thoracic, General and Oncological Surgery, Medical University of Lodz, 90-151 Lodz, Poland.

出版信息

Cancers (Basel). 2023 Oct 11;15(20):4935. doi: 10.3390/cancers15204935.

DOI:10.3390/cancers15204935
PMID:37894302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10605430/
Abstract

The importance of microbiota in developing and treating diseases, including lung cancer (LC), is becoming increasingly recognized. Studies have shown differences in microorganism populations in the upper and lower respiratory tracts of patients with lung cancer compared to healthy individuals, indicating a link between dysbiosis and lung cancer. However, it is not only important to identify "which bacteria are present" but also to understand "how" they affect lung carcinogenesis. The interactions between the host and lung microbiota are complex, and our knowledge of this relationship is limited. This review presents research findings on the bacterial lung microbiota and discusses the mechanisms by which lung-dwelling microorganisms may directly or indirectly contribute to the development of lung cancer. These mechanisms include influences on the host immune system regulation and the local immune microenvironment, the regulation of oncogenic signaling pathways in epithelial cells (causing cell cycle disorders, mutagenesis, and DNA damage), and lastly, the MAMPs-mediated path involving the effects of bacteriocins, TLRs signaling induction, and TNF release. A better understanding of lung microbiota's role in lung tumor pathology could lead to identifying new diagnostic and therapeutic biomarkers and developing personalized therapeutic management for lung cancer patients.

摘要

微生物群在包括肺癌(LC)在内的疾病发生和治疗中的重要性日益得到认可。研究表明,与健康个体相比,肺癌患者上、下呼吸道的微生物种群存在差异,这表明生态失调与肺癌之间存在联系。然而,不仅要确定“存在哪些细菌”,还要了解它们“如何”影响肺癌的发生。宿主与肺部微生物群之间的相互作用很复杂,我们对这种关系的了解有限。这篇综述介绍了关于肺部细菌微生物群的研究结果,并讨论了肺部微生物可能直接或间接促进肺癌发展的机制。这些机制包括对宿主免疫系统调节和局部免疫微环境的影响、上皮细胞中致癌信号通路的调节(导致细胞周期紊乱、诱变和DNA损伤),以及最后涉及细菌素作用、TLR信号诱导和TNF释放的MAMPs介导途径。更好地了解肺部微生物群在肺肿瘤病理学中的作用可能会导致识别新的诊断和治疗生物标志物,并为肺癌患者制定个性化的治疗方案。

相似文献

1
Respiratory Tract Oncobiome in Lung Carcinogenesis: Where Are We Now?肺癌发生过程中的呼吸道肿瘤微生物组:我们目前的进展如何?
Cancers (Basel). 2023 Oct 11;15(20):4935. doi: 10.3390/cancers15204935.
2
Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected.肺癌呼吸道不同部位的共生微生物群落以及受影响的潜在宿主免疫过程。
Front Cell Infect Microbiol. 2024 Feb 2;14:1296295. doi: 10.3389/fcimb.2024.1296295. eCollection 2024.
3
Breast cancer: the first comparative evaluation of oncobiome composition between males and females.乳腺癌:男性和女性之间oncobiome 组成的首次比较评估。
Biol Sex Differ. 2023 Jun 5;14(1):37. doi: 10.1186/s13293-023-00523-w.
4
The Oncobiome in Gastroenteric and Genitourinary Cancers.消化系统肿瘤和泌尿生殖系统肿瘤的肿瘤微生物组。
Int J Mol Sci. 2022 Aug 26;23(17):9664. doi: 10.3390/ijms23179664.
5
Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.短链脂肪酸:肠-肺轴的基本介质及其在肺部疾病中的作用。
Chem Biol Interact. 2022 Dec 1;368:110231. doi: 10.1016/j.cbi.2022.110231. Epub 2022 Oct 23.
6
Oncobiome at the Forefront of a Novel Molecular Mechanism to Understand the Microbiome and Cancer.Oncobiome 处于理解微生物组与癌症的新型分子机制的前沿。
Adv Exp Med Biol. 2019;1168:147-156. doi: 10.1007/978-3-030-24100-1_10.
7
Microbiome: A Supportive or a Leading Actor in Lung Cancer?微生物组:肺癌的支持者还是主导者?
Pathobiology. 2021;88(2):198-207. doi: 10.1159/000511556. Epub 2020 Dec 22.
8
The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?肠道菌群在胃肠道癌症和癌症治疗中的作用:是机会还是诅咒?
Cell Mol Gastroenterol Hepatol. 2022;13(3):857-874. doi: 10.1016/j.jcmgh.2021.08.013. Epub 2021 Sep 8.
9
Prebiotic effects: metabolic and health benefits.益生元作用:代谢与健康益处。
Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363.
10
Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions.肠道微生物群与妇科癌症:发病机制总结及未来方向
ACS Infect Dis. 2021 May 14;7(5):987-1009. doi: 10.1021/acsinfecdis.0c00839. Epub 2021 Apr 13.

引用本文的文献

1
Lower Respiratory Tract Microbiome Signatures of Health and Lung Cancer Across Different Smoking Statuses.不同吸烟状态下健康与肺癌的下呼吸道微生物组特征
Cancers (Basel). 2025 Aug 13;17(16):2643. doi: 10.3390/cancers17162643.
2
The Current Roadmap of Lung Cancer Biology, Genomics and Racial Disparity.肺癌生物学、基因组学与种族差异的当前路线图
Int J Mol Sci. 2025 Apr 17;26(8):3818. doi: 10.3390/ijms26083818.

本文引用的文献

1
Lower respiratory tract microbiome composition and community interactions in smokers.吸烟者下呼吸道微生物组的组成及群落相互作用
Access Microbiol. 2023 Mar 21;5(3). doi: 10.1099/acmi.0.000497.v3. eCollection 2023.
2
The Cystic Fibrosis Upper and Lower Airway Metagenome.囊性纤维化上、下呼吸道宏基因组
Microbiol Spectr. 2023 Mar 9;11(2):e0363322. doi: 10.1128/spectrum.03633-22.
3
Biological and Genetic Mechanisms of COPD, Its Diagnosis, Treatment, and Relationship with Lung Cancer.慢性阻塞性肺疾病的生物学和遗传机制、诊断、治疗及其与肺癌的关系
Biomedicines. 2023 Feb 3;11(2):448. doi: 10.3390/biomedicines11020448.
4
Pulmonary Delivery of Emerging Antibacterials for Bacterial Lung Infections Treatment.新兴抗菌药物肺部递药治疗细菌性肺部感染
Pharm Res. 2023 May;40(5):1057-1072. doi: 10.1007/s11095-022-03379-8. Epub 2022 Sep 19.
5
Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora.人类微生物组在癌症发展和对治疗的反应中的新作用:特别关注肠道微生物群。
J Transl Med. 2022 Jul 6;20(1):301. doi: 10.1186/s12967-022-03492-7.
6
Alterations of lung microbiota in patients with non-small cell lung cancer.非小细胞肺癌患者肺部微生物组的改变。
Bioengineered. 2022 Mar;13(3):6665-6677. doi: 10.1080/21655979.2022.2045843.
7
The airway microbiota of non-small cell lung cancer patients and its relationship to tumor stage and EGFR gene mutation.非小细胞肺癌患者的气道微生物群及其与肿瘤分期和 EGFR 基因突变的关系。
Thorac Cancer. 2022 Mar;13(6):858-869. doi: 10.1111/1759-7714.14340. Epub 2022 Feb 10.
8
Potential Association Between Changes in Microbiota Level and Lung Diseases: A Meta-Analysis.微生物群水平变化与肺部疾病之间的潜在关联:一项荟萃分析。
Front Med (Lausanne). 2022 Jan 14;8:723635. doi: 10.3389/fmed.2021.723635. eCollection 2021.
9
Oral Species and Their Connection to Events of Clinical Relevance in Gastrointestinal and Respiratory Tracts.口腔物种及其与胃肠道和呼吸道临床相关事件的联系。
Front Microbiol. 2022 Jan 6;12:798763. doi: 10.3389/fmicb.2021.798763. eCollection 2021.
10
Links between Infections, Lung Cancer, and the Immune System.感染、肺癌与免疫系统之间的联系。
Int J Mol Sci. 2021 Aug 30;22(17):9394. doi: 10.3390/ijms22179394.